PharmaCyte Biotech Inc (PMCB)

[rudygerner]

Billions of dollars of insulin revenue is worth protecting at any/all costs. I believe PMCB (formerly Nuvilex) has sustained prolonged cyber attacks from multiple offshore accounts, likely funded by a big pharma or quite possibly multiple big pharmas.

https://globenewswire.com/news-release/2016/08/25/866781/0/en/Human-Insulin-Market-Poised-to-Surge-from-USD-27-0-Billion-in-2015-to-USD-43-6-Billion-Globally-by-2021-ZionMarketResearch-Com.html


The Cell-in-a-Box®/Melligen cell combo to treat diabetes eliminates the need for insulin, effectively curing both type 1 and type 2 diabetes.

Furthermore, a cure for diabetes could also generate billions of dollars more if there are carryover benefits to other diseases. The Cell-in-a-Box® technology is about to enter the clinic for pancreas cancer: clearly this technology has carryover benefits. A cure for diabetes could also make for lucrative licensing agreements and exclusivity pacts for future drugs, grants, and strategic alliances. NDA's (non-disclosure agreements) are already in place. "... the company also is assessing the interest of big pharmas, and many have signed non-disclosure agreements. “We’ve been approached by a number of people who want to get involved,” Waggoner said. “They’ve recognized that our treatment is very different from any approach that’s out there.”" http://pharmacyte.com/pharmacyte-seeks-to-solve-pancreas-puzzle-with-cell-in-a-box/